Domain Registration Corp Successfully Completes Reve...(nistration and governmententities in Jil...),Health

"We are very pleased to become a public company in the United States and appreciate the broad support we have received for our efforts, as evidenced by our recent press conference in China. The completion of this transaction enables us to broaden our investor base, create a liquid market for our stock, and financially support the accelerated growth of our business," said Yunlu Yin, Chief Executive Officer. "We will continue to strive towards our goal of becoming an internationally integrated healthcare and pharmaceutical group via sustained industry mergers and acquisitions."

China's pharmaceutical industry has increased 16.8% annually over the past 30 years, with a total revenue of USD120.4 billion in 2008, representing an increase of 24.9% compared to 2007. However, China's medicine retail market remains highly fragmented, with chain store retail as low as 20% compared to developed countries like the U.S. that enjoy 64% of the market.

In order to combat this, on January 21, 2009, the central government released its New Healthcare Innovation Scheme (NHIS), which will significantly boost medicine retailing in China. As part of this new plan, online, telephone and mail medicine retail services will be stipulated by the central government, and these reforms will generate significant changes in the medicine retailing market, while the most powerful distribution channels will have significant advantages compared to the competition.

Under this climate of reform, the Company has begun implementing measures to strengthen its core competitiveness including mergers and acquisitions, and strategic alliances, while also enhancing its scale of operations by introducing new products and expanding its sales networks to increase market share.

About
'/>"/>